update on bayer crdf hlb project - florida citrus...
TRANSCRIPT
///////////
Update on Bayer CRDF HLB Project
Florida Citrus Industry Annual Conference,Bonita Springs
June 14, 2018 / Denise Manker
== =Plant
Defense Modulator
Abandoned groves / backyard citrus
NurseryEradi-cation
Plant Health & Defense
Systemic & contact insecti-cides
Anti-bacterial solutions
NutritionManage-
ment
IrrigationManage-
ment
Monito-ring /Traps
Tree Inspec-
tion
Partne-ring
Parasitoid BeneficialsRoot
Health Manage-
ment
Regional Manage-
ment / CHMas
Orchards
Pathogen
HostPlant DefenseModulators
Antibacterial Microbes
Vector
Nutrition Manage-
ment
Induce resistance and strengthen
plant health
Avoid / Stop multiplication
of the bacterium
HLB Screening Cascade
The Project Will Pursue Three Key Elements to Find a Solution for HLB
Allows systematic search for solutions
against HLB
1 2 3
What is unique about this approach?
HLB Screening Cascade
Allows systematic search for solutions
against HLB
1Focus on developing a validated screening cascade
• Purpose is to have a systematic approach to identify and characterize hits with confirmed in planta HLB activity
• Develop in house high through-put in vitro Liberibactercrescens assay along with other bacterial targets
• Collaborate with academic lab to optimize Liberibactersolanacearum in planta assay greenhouse for screening leads
• Fund development of a validated in planta HLB citrus greenhouse assay to select leads for field testing in 2019
Dose-response bacterial cell tests including
Liberibacter crescens
HitSelection
Planta test other bacterial diseases and citrus
usabiltiy
Citrus field trials
Lead Selection
D
HLB Specific Screening Cascade: from Cell Test to Field
Chemical judgement: novelty, chemical variability, PhysChem Biological judgement: Disease potential, activity, mode of action
Selected strains (AM)
Plant Defense Modulators (PDM)
internal external
Tox package for fieldIntellectual Property
De-selection of unwanted strains
Greenhouse test on citrus
Liberibacter solanacearumon tomato GH test
HLB specific screening cascade will allow systematic approach for testing, selecting and optimizing strains and compounds for efficacy against HLB.
What is unique about this approach?Develop pool of candidates that target both Pathogen and Host and would have relatively shorter regulatory path to market
• Host Approach: Screen synthetic compound libraries for their ability to control Liberibacter indirectly via induction of plant defense pathways
Advantages:• Indirect activity – not a pesticide/bactericide, low risk of
resistance• Bayer has a screen in place for discovering Plant
Defense Modulators (PDM) for other bacterial diseases so can rapidly identify chemical classes
Plant DefenseModulators
Induce resistance and strengthen
plant health
2
Induced systemic response• Broad spectrum• Long lasting• Low risk of resistance
• Xanthomonas cabbage assay has been optimized
• Pseudomonas tomato assays developed
• Citrus established in greenhouse for phytotoxicity tests
• In planta citrus PDM assay under development
• One chemistry class has been identified which can protect plants from bacterial disease via plant defense mechanism
A library of compounds in this class is being synthesized for further testing/optimization activity
Progress on Plant Defense Modulators
Pseudomonas on tomato, Bayer
Plant tests for other bacterial diseases and
citrus compatibility
Citrus plantlets, Bayer
• Proof of concept of multiple marker tracking• Low Throughput Screen to be routine in Q3-2018
Citrus Molecular Diagnostic – HLB disease free test
Plant Defense test in Citrus plantlets HLB disease free test
Bayer Partnership with CRDF
What would that look like?
Plant Defense Product
Foliar spray
Likely PreventativeMay need multiple applicationsFoliar spray best application method
What is unique about this approach?
Develop pool of candidates that target both Pathogen and Host and would have relatively shorter regulatory path to market
• Pathogen Approach: Screen microorganisms that can directly inhibit Liberibacter through production of anti-bacterial compounds
Advantages:• Active microbes can be registered through EPA’s BPPD in
an expedited process• Bayer has a collection of >150,000 microbial strains and
sophisticated in-silico screening capabilities to identify strains that are likely to be anti-bacterial
Antibacterial Microbes
Avoid / Stop multiplication of the bacterium
3
Global Biological R&D Center in West Sacramento, CA• $80 Mio facility on 10 acres
• ~170,000 sq. ft including pilot plant
• Biologics staff of 105 people
• Additional 5 acres for greenhouse
Using this method, 100 strains selected to validate assays and first 1000 strains selected for screening
In-silico screening of Bayer’s microbial library
Page 11
?
AntiBac
GENOME
A TG CSequencing
FunctionalGenomics
MicrobialGenome Portal
The genetics of isolates are used to select strains predicted to have anti-bacterial biological chemistry
Bayer Partnership with CRDF
Progress on Antibacterial Microbes
In vitro Assays – XANTAV, PSDMTM, ERWIAM, and CORBMI with L. Crescens – under development
In Planta Assays – XANTAV and PSDMTM (RALSSO in development)
Serenade Treated Untreated
Xanthomonas Assay
• MIC assays in place for Xanthomonas, Pseudomonas, Agrobacterium
• Working on method transfer for L. crescens in vitro assay
• Agar diffusion plate assays developed for Xanthomonas, Pseudomonas, Erwinia and Clavibacter
• Plant bioassays in place for Xanthomonas and Pseudomonas
• Plant assay for Ralstonia under development
Enriched active fraction has been prepared for first plant testing in tomato and citrus tests
Advanced microbial lead chemically characterized
13
Several microbial strains from advanced projects were previously identified to be active in vitro on Liberibacter crescens
AQ713 –antibacterial activity identified, concentrated samples prepared for in planta tests
AQ2808 -- initial chemical characterization is underway with good progress being made
Remaining leads awaiting further chemical analysis
Bayer Partnership with CRDF
What would that look like?
Anti-bacterial Microbial Product
Trunk Injection?
• How to get the microbe to the infection?• May require trunk injection• Should have direct activity on pathogen
so possibly work on infected trees?
Collaborations with University of California Davis and University of Florida
External collaborations for greenhouse screening
Page 15
UC Davis, Bryce Falk, Sandra Thuy Vu. Liberibacter solanacearum assay on tomato.Psyllid inoculated. qPCR analysis. No containment required. First samples ofadvanced microbial lead are in test.
Univ. of Florida, Southwest Florida Researchand Education Center, Ozgur Batuman has developed an HLB in planta greenhouse assay on citrus. Psyllid inoculated. qPCR analysis.First samples for testing to be shipped in June.
Bayer Partnership with CRDF
Strain Improvement
Field trials
Field trials
PRIO
RO
TIZA
TIO
N
Project Milestones
Page 16
Setup Routine Screening
Set Coll
Set Coll Method Development
potentially substituted by GH citrusRoutine Screening
Routine ScreeningField trials HLB
GH Citrus HLB
Plant Tests (not HLB)
Cell Test
PDM Screen Existing
AMIdentification of active strains
Optimization
Set Coll
Routine Screening
Set-Up + Test Phase
Follow-up advanced strains with known bactericidal activity
Setup
MilestonesMS 1 MS 2 MS 3 MS 4 MS 5
SETUP OPTIMIZATION
FIELDFIELD set-up
Joint SC Meeting STAR
T:
May
1
2017 2018 2019 2020 2021PROJECT STAGE I PROJECT STAGE II
Bayer Partnership with CRDF
Progress towards Milestones
Page 17
Milestone 1: Q4 2017 (~ 6 months): COMPLETED Setup of staff completed according to Budget Selection / prioritization
PDM chemistry starting points AMs to be screened first
Milestone 2: Aug 2018 (~ 15 months) Screening Cascade Cell test: workflow established -- Validation in process Lsol tomato test: cooperation / workflow established--
operational GH citrus test: identification of collaborator, contract setup
and method development initiated – Ahead of schedule PDM + AM Screening results of first examples in initial tests
obtained -- UNDERWAY Activity of advanced strains in Lsol system known – FIRST
LEADS BEING TESTED
Bayer Partnership with CRDF
=
HLB Screening Cascade
Greenhouse* and field trials
evaluation of solutions against HLB
Host
Induce resistance & strengthen plant health
Pathogen
Avoid/Stop multiplication of the bacterium
=
Antibacterial Microbes (AM)
Strain selection by genomic dereplicationDose response against
bacterial diseases
=Plant Defense
Modulators (PDM)
Optimization of chemistry against bacterial diseases
on planta testWith citrus compatibility
Highlights first thirteen months:
Plant Defense• Process for selecting PDM hits and optimizing chemistry in place• 1 Lead compound in Hit Exploration ph 0.1 – ready for testing in
tomato and citrus plant assays• Seven additional PDM chemical families identified for further work
Anti-bacterial Microbes• In vitro assays, including Liberibacter crescens, established,
429 of first 500 strains screened• Total of 1000 strains selected for screening using genomic
information• Activity in one advanced strain identified
Screening cascade• Research agreement with UCD* in place, assay and application
methods being validated, advanced microbe lead extract in test• Research agreement with UF** in place, trees infected, assay
being validated, advanced microbe extract lead ready for shipping
*UF : University of Florida, UC Davis
CRDF COLLABORATIONCross-Technology & Cross-Sites Project to bring our newly established bacterial diseases platform to the next level
Bayer CRDF agreement -- 13 month summary
19
• On track to produce leads for 2019 field trials vs HLB
• Screening cascade expected to be ready for routine testing in Q3
• Good progress on collaborator in planta assays vs Liberibacter (CA, FL)
• Promising PDM chemical class to be tested in greenhouse Liberibacter assays in July
• Validation and optimization of primary in vitro screen in process in Sacramento
• Activity identified in advanced microbial lead with concentrated material in test in tomato Lsol assay
• 1000 strains selected through genomic analysis for in vitro screening
Silver bullet is unlikely for a solution to HLB
/// IHC 2018 /// August 201820
The complexity and speed of spreading the disease shows clearly that multiple tools will be needed to manage HLB
We will need all available tools working together to address this challenge
Below are examples of approaches being explored by other parties
Psyllid control innovations
Breeding resistant citrus trees
Using genome editing and transgenic trees
Endophytes
ThankYou!
Bayer and Monsanto will create a global leader in sustainable agriculture
22
InnovationEngine
SocialResponsibility
Commitment to Sustainability
Bayer Partnership with CRDF
Focus on Sustainable Horticulture through Innovation
Why citrus matters to us…
23
Focus• With 25%, horticulture accounts for the largest share of our business. • Leader of the global citrus crop protection segment.• Citrus is our No. 1 horticulture crop in the US and Brazil.• Leading company in crop protection research and technology.
Innovation• Our company mission is the foundation of what we strive to achieve within
agriculture. • We help to secure the supply of high-quality, affordable food.• We invest about 10 percent of our annual sales in R&D, and a significant part into
horticulture.
Commitment for sustainable horticulture:• The current Citrus Greening management practices are not sustainable.• To secure future citrus fruit supply, the way of cultivation needs to change. • Sustainable agriculture is the only way to overcome the challenge.
Bayer Partnership with CRDF
How will divestment affect Bayer’s CRDF project?
24
Effect on CRDF Agreement
Divestment announcement
25
The divestment of Morrisville Traits research affected CRDF agreement by:
-- Loss of one FTE, transferred to BASF
-- Loss of site/access to High Throughput Screening (HTS)
Activities to mitigate these effects:
Replacement FTE hired, internal post-doc transferred to project allowing for quick start
Transfer and validation of HTS currently underwayTaking opportunity to modify process to enhance discovery of active microbial metabolites
RESULT: Approximately two months behind in screening AM’s in vitro
Long term gains: More efficient process – no shipping of strains and extracts between CA and NCMedia optimized for metabolite production
Bayer Partnership with CRDF